Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

High Throughput Flow Assay Trends 2017: Results of

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 59)
Posted On: 07/14/2017 4:00:24 AM
Avatar
Posted By: News Desk 2018
High Throughput Flow Assay Trends 2017: Results of HTStec's Industry-Wide Global Web-Based Benchmarking Survey

Dublin, July 14, 2017 (GLOBE NEWSWIRE) -- The "High Throughput Flow Assay Trends" report has been added to Research and Markets' offering. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on high throughput flow cytometry (HT flow) screening carried out in January 2017. The survey was initiated as part of the publisher's tracking of emerging life science marketplaces and to update the previous HT Flow Assay Trends report 2015. The questionnaire was compiled to meet the needs, requirements and interests of the flow cytometry vendor community. The objectives were to document the current implementation and use of HT flow assays in screening, and to understand future user requirements. The aim was to compile a reference document on HT flow assays, which could be compared directly relative to our previous 2015 report. Equal emphasis was given to soliciting opinion from the large molecule, small molecule and immunoassay screening segments worldwide. The survey looked at the following aspects of HT flow screening, as practiced today (2017) and in a few cases as predicted for the future (2019):

  • Why respondents have enabled or why they are interested in HT flow
  • How respondents have achieved HT flow analysis to date and typical throughput realised with current instrument approach
  • Will implementation of HT flow mainly displace or complement existing screening technologies
  • Key diseases/therapeutic areas targeted with HT flow screening
  • Target classes most interested in applying HT flow assays
  • Broad applications areas most using or most considering using HT flow assays
  • Key applications for HT flow in respondent's research
  • Main benefits of HT flow versus other techniques
  • Plate processing time considered adequate for HT flow needs
  • Preferred sample presentation/handling format for HT flow and the target sample (aspirate) volume
  • Number of parameters to be multiplexed in cell-based HT flow assays
  • Number of analytes to be multiplexed in bead-based HT flow assays
  • Samples types to be analysed with HT flow
  • Where cell markers of interest in HT flow screens are located
  • Main cell labelling technique/source
  • Type of endpoints of most interest in HT flow screens
  • Intention to carry out any front end processing or sample preparation prior to HT flow
  • Number of different primary screens and number of wells to be tested per screen for cell-based and bead-based HT flow assays
  • Estimated cost per sample (microplate well) analysed using cell-based and bead-based HT flow assays
  • Vendor that first comes to mind when thinking of flow cytometry in general and HT flow specifically
  • Plans to purchase any instrumentation to enable HT flow assays
  • Capex budget for HT flow detection instruments
  • Reagents and consumables budget for HT flow assays
  • How respondents have deployed HT flow instrumentation into their screening environment/core facility
  • Biggest limitations (obstacles) in using HT flow assays today
  • Ratings of possible limitations of HT flow
  • Biggest hurdles in software and data analysis for HT flow
  • Level of agreement with statements about the status of HT flow assays
  • And any unmet needs in HT flow screening today.

For more information about this report visit https://www.researchandmarkets.com/research/n...throughput

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Laboratory Equipment



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us